Literature DB >> 12213971

Oxidative stress and diabetic cardiomyopathy: a brief review.

L Cai1, Y J Kang.   

Abstract

Diabetes is a serious public health problem. Improvements in the treatment of noncardiac complications from diabetes have resulted in heart disease becoming a leading cause of death in diabetic patients. Several cardiovascular pathological consequences of diabetes such as hypertension affect the heart to varying degrees. However, hyperglycemia, as an independent risk factor, directly causes cardiac damage and leads to diabetic cardiomyopathy. Diabetic cardiomyopathy can occur independent of vascular disease, although the mechanisms are largely unknown. Previous studies have paid little attention to the direct effects of hyperglycemia on cardiac myocytes, and most studies, especially in vitro, have mainly focused on the molecular mechanisms underlying pathogenic alterations in vascular smooth-muscle cells and endothelial cells. Thus, a comprehensive understanding of the mechanisms of diabetic cardiomyopathy is urgently needed to develop approaches for the prevention and treatment of diabetic cardiac complications. This review provides a survey of current understanding of diabetic cardiomyopathy. Current consensus is that hyperglycemia results in the production of reactive oxygen and nitrogen species, which leads to oxidative myocardial injury. Alterations in myocardial structure and function occur in the late stage of diabetes. These chronic alterations are believed to result from acute cardiac responses to suddenly increased glucose levels at the early stage of diabetes. Oxidative stress, induced by reactive oxygen and nitrogen species derived from hyperglycemia, causes abnormal gene expression, altered signal transduction, and the activation of pathways leading to programmed myocardial cell deaths. The resulting myocardial cell loss thus plays a critical role in the development of diabetic cardiomyopathy. Advances in the application of various strategies for targeting the prevention of hyperglycemia-induced oxidative myocardial injury may be fruitful.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12213971     DOI: 10.1385/ct:1:3:181

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  109 in total

1.  Role of cardiac isoform of alpha-2 macroglobulin in diabetic myocardium.

Authors:  Sowmya Soman; C S Manju; Arun A Rauf; M Indira; C Rajamanickam
Journal:  Mol Cell Biochem       Date:  2010-12-25       Impact factor: 3.396

2.  EPR studies on the superoxide-scavenging capacity of the nutraceutical resveratrol.

Authors:  Zhenquan Jia; Hong Zhu; Bhaba R Misra; James E Mahaney; Yunbo Li; Hara P Misra
Journal:  Mol Cell Biochem       Date:  2008-04-13       Impact factor: 3.396

3.  Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway.

Authors:  Chi Zhang; Zhifeng Huang; Junlian Gu; Xiaoqing Yan; Xuemian Lu; Shanshan Zhou; Shudong Wang; Minglong Shao; Fangfang Zhang; Peng Cheng; Wenke Feng; Yi Tan; Xiaokun Li
Journal:  Diabetologia       Date:  2015-06-04       Impact factor: 10.122

Review 4.  Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy.

Authors:  Rokhsana Mortuza; Subrata Chakrabarti
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

5.  Spirulina platensis prevents high glucose-induced oxidative stress mitochondrial damage mediated apoptosis in cardiomyoblasts.

Authors:  Pratiksha Jadaun; Dhananjay Yadav; Prakash Singh Bisen
Journal:  Cytotechnology       Date:  2017-07-12       Impact factor: 2.058

Review 6.  Zinc homeostasis in the metabolic syndrome and diabetes.

Authors:  Xiao Miao; Weixia Sun; Yaowen Fu; Lining Miao; Lu Cai
Journal:  Front Med       Date:  2013-02-06       Impact factor: 4.592

7.  Cardiac overexpression of catalase rescues cardiac contractile dysfunction induced by insulin resistance: Role of oxidative stress, protein carbonyl formation and insulin sensitivity.

Authors:  F Dong; C X Fang; X Yang; X Zhang; F L Lopez; J Ren
Journal:  Diabetologia       Date:  2006-04-04       Impact factor: 10.122

8.  Asymmetric dimethylarginine induces endothelial nitric-oxide synthase mitochondrial redistribution through the nitration-mediated activation of Akt1.

Authors:  Ruslan Rafikov; Olga Rafikova; Saurabh Aggarwal; Christine Gross; Xutong Sun; Julin Desai; David Fulton; Stephen M Black
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

9.  The phosphodiesterase-5 inhibitor vardenafil improves cardiovascular dysfunction in experimental diabetes mellitus.

Authors:  T Radovits; T Bömicke; G Kökény; R Arif; S Loganathan; K Kécsán; S Korkmaz; E Barnucz; P Sandner; M Karck; G Szabó
Journal:  Br J Pharmacol       Date:  2009-03-04       Impact factor: 8.739

10.  Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidants.

Authors:  Michael F Hill
Journal:  Curr Cardiol Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.